• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
DONG Xiaoyang, WANG Ziyu, WANG Yongchao, DAI Zhenya, YOU Qidong. Recent progress in asymmetric organocatalysis and its applications in drug synthesis[J]. Journal of China Pharmaceutical University, 2013, 44(3): 193-201. DOI: 10.11665/j.issn.1000-5048.20130301
Citation: DONG Xiaoyang, WANG Ziyu, WANG Yongchao, DAI Zhenya, YOU Qidong. Recent progress in asymmetric organocatalysis and its applications in drug synthesis[J]. Journal of China Pharmaceutical University, 2013, 44(3): 193-201. DOI: 10.11665/j.issn.1000-5048.20130301

Recent progress in asymmetric organocatalysis and its applications in drug synthesis

More Information
  • In the past decade, thousands of chiral organocatalysts have emerged for asymmetric synthesis, and opened up new channels and shortcuts, especially in the synthesis of chiral drug intermediates. They play an important role in developing new methods for the synthesis of new drugs. In these review, chiral organocatalytic reactions are summarized and classified based on the interaction manner way between chiral organocayalysts and substrates. The latest developments of organocatalysis and their applications in drug synthesis are present hereinafter for exploring and developing better organocatalysis.
  • Related Articles

    [1]LI Yin, GU Hongfeng, ZOU Yi, WANG Shuping, XU Yungen. Research progress of mono-(ADP-ribosyl) transferase family and their inhibitors in tumor therapy[J]. Journal of China Pharmaceutical University, 2021, 52(6): 643-652. DOI: 10.11665/j.issn.1000-5048.20210601
    [2]SUN Chenkai, CHEN Xin, CHENG Hao, ZHANG Xiangze, YANG Xiaoyu, ZHOU Jianping, DING Yang. Advances of research on oxygen-enhancing nano-delivery system for photodynamic therapy[J]. Journal of China Pharmaceutical University, 2021, 52(4): 387-397. DOI: 10.11665/j.issn.1000-5048.20210401
    [3]FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406
    [4]TANG Keqin, LIN Huaqing, LI Shuhong, DONG Lixin, LU Bohong, JIANG Hong. Advances in tumor targeted nanocrystals[J]. Journal of China Pharmaceutical University, 2020, 51(4): 418-424. DOI: 10.11665/j.issn.1000-5048.20200405
    [5]CHEN Ye, YIN Jun, YAO Wenbing, GAO Xiangdong. Advances of DNA-based nanomaterials in tumor therapy[J]. Journal of China Pharmaceutical University, 2020, 51(4): 406-417. DOI: 10.11665/j.issn.1000-5048.20200404
    [6]XU Xiangting, WANG Wei. Advances of functionalized carbon nanotubes in diagnosis and treatment of tumor[J]. Journal of China Pharmaceutical University, 2018, 49(2): 165-172. DOI: 10.11665/j.issn.1000-5048.20180205
    [7]CAI Han, LIU Yanhong, YIN Tingjie, ZHOU Jianping, HUO Meirong. Advances in the targeted therapy of tumor-associated fibroblasts[J]. Journal of China Pharmaceutical University, 2018, 49(1): 20-25. DOI: 10.11665/j.issn.1000-5048.20180103
    [8]WANG Letian, WANG Jinglin, LIU Hongwu, GE Ying, LI Yuyan, XU Qingxiang. Process in targeted contrast agents for cancer imaging[J]. Journal of China Pharmaceutical University, 2017, 48(6): 635-645. DOI: 10.11665/j.issn.1000-5048.20170602
    [9]DONG Hong, WU Ruixue, LIU Jiaqi, HUANG Qing, ZHOU Ya, HU Yiqiao. Advances in cancer photodynamic therapy[J]. Journal of China Pharmaceutical University, 2016, 47(4): 377-387. DOI: 10.11665/j.issn.1000-5048.20160401
    [10]HUANG Shaoliang, ZHAO Li, GUO Qinglong, WU Yulin. Advances of Hedgehog pathway in tumor resistance[J]. Journal of China Pharmaceutical University, 2016, 47(3): 259-266. DOI: 10.11665/j.issn.1000-5048.20160302

Catalog

    Article views (1957) PDF downloads (2932) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return